Performance of Fully-Automated High-Throughput Plasma Biomarker Assays for Alzheimer’s Disease in Amnestic Mild Cognitive Impairment Subjects - 21/11/24
, M.G. Vita 1, E.M. Costantini 1, S. Citro 1, 2, 3, C. Carrozza 4, G. De Ninno 4, P. Calabresi 1, 3, C. Marra 2, 3
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Abstract |
Introduction |
Novel plasma biomarkers are promising for identifying Alzheimer’s disease (AD) pathological processes in vivo, but most currently employed assays have limitations precluding widespread use.
Methods |
CSF and plasma samples were collected from seventy amnestic mild cognitive impairment (aMCI) subjects, stratified as A+ and A−. CSF Aβ40, Aβ42, p-tau181 and t-tau and plasma Aβ40, Aβ42 and p-tau181 quantification were conducted using the Lumipulse G assays (Fujirebio), to evaluate the diagnostic performance of plasma biomarkers and assess their associations with CSF biomarkers.
Results |
All plasma biomarkers except Aβ40 showed a very good accuracy in distinguishing A+ aMCI from A− aMCI, Aβ42/p-tau181 ratio being the most accurate (AUC 0.895, sensitivity 95.1%, specificity 82.8%). Plasma biomarkers levels were significantly associated with CSF biomarkers concentration.
Discussion |
High-throughput and fully-automated plasma assays could be helpful in discriminating with high accuracy between aMCI in the AD continuum and aMCI unlikely due to AD in clinical settings.
Il testo completo di questo articolo è disponibile in PDF.Key words : Alzheimer’s disease (AD), amnestic mild cognitive impairment (aMCI), blood-based biomarkers, plasma biomarkers, fully-automated assays
Mappa
Vol 11 - N° 4
P. 1073-1078 - Agosto 2024 Ritorno al numero
Articolo precedente
- Female Reproductive Factors and Risk of Mild Cognitive Impairment and Dementia: The HUNT Study
- Yehani Wedatilake, C. Myrstad, S.E. Tom, B.H. Strand, S. Bergh, G. Selbæk
- Interest in and Experience with Genetic Testing for Late-Onset Medical Conditions: Results from the National Poll on Healthy Aging
- S.J. Feldman, D. Blasco, M. Mones, J. Scott Roberts
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.